Anesthesia and myopathy

Current Opinion in Anaesthesiology

Volumn 15, Issue 3, 2002, Pages 371-376

  Baraka, Anis S ^a   Jalbout, Maya I ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

ICU myopathy; Muscle relaxants; Myopathy; Neuromuscular disorders

Indexed keywords

CHOLINERGIC RECEPTOR; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INHALATION ANESTHETIC AGENT; MUSCLE RELAXANT AGENT; NEUROMUSCULAR BLOCKING AGENT; SUXAMETHONIUM;

ANESTHESIA; DENERVATION; DISEASE CLASSIFICATION; HUMAN; INHALATION ANESTHESIA; INTENSIVE CARE UNIT; MALIGNANT HYPERTHERMIA; MUSCULAR DYSTROPHY; MYASTHENIA GRAVIS; MYOPATHY; MYOTONIC DYSTROPHY; NEUROMUSCULAR TRANSMISSION; PLASMAPHERESIS; PRIORITY JOURNAL; REGIONAL ANESTHESIA; RESPIRATORY FAILURE; REVIEW; THYMECTOMY;

EID: 0036266686     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200206000-00016     Document Type: Review

References (48)

1. Anaesthesia in lipid myopahty
2. Neuromuscular-blocking drugs: Use and misuse in the intensive care unit
3. Critical illness myopathy
4. Suxamethonium-induced muscle contracture follows traumatic denervation in man
5. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers
6. Advances in neurobiology of the neuromuscular junction: Implications for the anesthesiologist
7. Cardiac arrest after succinylcholine. Mortality greater with rhabdomyolysis than receptor upregulation
8. Development regulation of nicotinic acetylcholine receptors
9. Prolonged d-tubocurarine infusion and/or immobilization cause upregulation of acetylcholine receptors and hyperkalemia to succinylcholine in rats
10. Intractable cardiac arrest in children given succinylcholine
11. Suxamethonium-induced rhabdomyolysis in a healthy middle-aged man
12. The prolonged effect of a muscle relaxant in a patient with chronic inflammatory demyelinating polyradiculoneuropathy
13. Problems of anesthesia in patients with neuromuscular disease
14. Autonomous peripheral nerve activity causing generalized muscle stiffness and fasciculations: Report of a case with physiological, pharmacological, and morphological observations
15. Exercise produces sensitivity to metocurine
16. Anesthesia and critical care of thymectomy for myasthenia gravis
17. Anaesthesia and myasthenia gravis
18. Myasthenia gravis
19. The margin of safety of neuromuscular transmission
20. Acetylcholine receptors and myasthenia
21. Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome
22. Studies on myasthenia gravis: Review of a twenty-years experience in over 1200 patients
23. Strategies for the treatment of myasthenia gravis
24. Myasthenia gravis: Recommendations for clinical research standards
25. Suxamethonium block in the myasthenic patient: Correlation with plasma cholinesterase
26. Repeated doses of suxamethonium in the myasthenic patient
27. Sevoflurane as a sole anesthetic for thymectomy in myasthenia gravis
28. Combination of balanced and regional anaesthesia for minimal invasive surgery in a patient with myasthenia gravis
29. Predictors of respiratory failure following transcervical thymectomy
30. The neurobiology of Duchenne muscular dystrophy: Learning lessons from muscles?
31. Cardiac involvement in primary myopathies
32. The coexistance of embryonic and adult acetylcholine receptor and the sarcolemma of dystrophic mouse muscle. An effect of regenerative or muscular dystrophy
33. Pediatric emergencies
34. Continuous propofol anaesthesia for patients with myotonic dystrophy
35. Control of succinylcholine-induced myotonia by d-tubocurarine
36. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree
37. North American malignant hyperthermia population screening of the ryanodine receptor gene an identification of novel mutation
38. Malignant hyperthermia in infancy and in elderly of a novel RyR1 mutation
39. Genetics and pathogenesis of malignant hyperthermia
40. Malignant hyperthermia: Advances in clinical management and diagnosis
41. An unusual case of malignant hyperthermia during desflurane anesthesia in African-American patient
42. Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis
43. Myopathy in critically ill
44. Clinical and electrophysiological findings in critical illness polyneuropathy
45. Critical illness neuropathy and myopathy
46. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels
47. Additive inhibition of nicotinic acetylcholine receptors by corticostroids and the neuromuscular blocking drug vecuronium
48. Acute quadreplegia myopathy in the intensive care unit: Time to look at a mechanistic approach